Unknown

Dataset Information

0

Next-generation sequencing identifies contribution of both class I and II HLA genes on susceptibility of multiple sclerosis in Japanese.


ABSTRACT: BACKGROUND:The spectrum of classical and non-classical HLA genes related to the risk of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) in the Japanese population has not been studied in detail. We conducted a case-control analysis of classical and non-classical HLA genes. METHODS:We used next-generation sequencing (NGS)-based HLA genotyping methods for mapping risk for 45 MS patients, 31 NMOSD patients, and 429 healthy controls. We evaluated the association of the HLA variants with the risk of MS and NMOSD using logistic regression analysis and Fisher's exact test. RESULTS:We confirmed that HLA-DRB1*15:01 showed the strongest association with MS (P =?2.1?×?10-5; odds ratio [OR]?=?3.44, 95% confidence interval [95% CI]?=?1.95-6.07). Stepwise conditional analysis identified HLA-DRB1*04:05, HLA-B*39:01, and HLA-B*15:01 as being associated with independent MS susceptibility (PConditional 

SUBMITTER: Ogawa K 

PROVIDER: S-EPMC6683481 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Next-generation sequencing identifies contribution of both class I and II HLA genes on susceptibility of multiple sclerosis in Japanese.

Ogawa Kotaro K   Okuno Tatsusada T   Hosomichi Kazuyoshi K   Hosokawa Akiko A   Hirata Jun J   Suzuki Ken K   Sakaue Saori S   Kinoshita Makoto M   Asano Yoshihiro Y   Miyamoto Katsuichi K   Inoue Ituro I   Kusunoki Susumu S   Okada Yukinori Y   Mochizuki Hideki H  

Journal of neuroinflammation 20190805 1


<h4>Background</h4>The spectrum of classical and non-classical HLA genes related to the risk of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) in the Japanese population has not been studied in detail. We conducted a case-control analysis of classical and non-classical HLA genes.<h4>Methods</h4>We used next-generation sequencing (NGS)-based HLA genotyping methods for mapping risk for 45 MS patients, 31 NMOSD patients, and 429 healthy controls. We evaluated the associa  ...[more]

Similar Datasets

| S-EPMC3033818 | biostudies-literature
| S-EPMC2834350 | biostudies-literature
| S-EPMC6365219 | biostudies-literature
| S-EPMC4446346 | biostudies-literature
| S-EPMC9214260 | biostudies-literature
| S-EPMC9166778 | biostudies-literature
| S-EPMC8701008 | biostudies-literature
| S-EPMC8215161 | biostudies-literature
| S-EPMC2892470 | biostudies-literature
| S-EPMC3350841 | biostudies-literature